JP2023521665A - サケ類油組成物を使用する呼吸器処置 - Google Patents

サケ類油組成物を使用する呼吸器処置 Download PDF

Info

Publication number
JP2023521665A
JP2023521665A JP2022560235A JP2022560235A JP2023521665A JP 2023521665 A JP2023521665 A JP 2023521665A JP 2022560235 A JP2022560235 A JP 2022560235A JP 2022560235 A JP2022560235 A JP 2022560235A JP 2023521665 A JP2023521665 A JP 2023521665A
Authority
JP
Japan
Prior art keywords
acid
salmon oil
disease
disorder
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022560235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023521665A5 (https=
Inventor
ボミ フラムローゼ，
Original Assignee
ホフセス バイオケア アーエスアー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ホフセス バイオケア アーエスアー filed Critical ホフセス バイオケア アーエスアー
Publication of JP2023521665A publication Critical patent/JP2023521665A/ja
Publication of JP2023521665A5 publication Critical patent/JP2023521665A5/ja
Priority to JP2025120711A priority Critical patent/JP2025142093A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022560235A 2020-04-07 2021-04-07 サケ類油組成物を使用する呼吸器処置 Pending JP2023521665A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025120711A JP2025142093A (ja) 2020-04-07 2025-07-17 サケ類油組成物を使用する呼吸器処置

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063006327P 2020-04-07 2020-04-07
US63/006,327 2020-04-07
US202063114960P 2020-11-17 2020-11-17
US63/114,960 2020-11-17
PCT/US2021/026193 WO2021207367A1 (en) 2020-04-07 2021-04-07 Respiratory treatments using salmonid oil compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025120711A Division JP2025142093A (ja) 2020-04-07 2025-07-17 サケ類油組成物を使用する呼吸器処置

Publications (2)

Publication Number Publication Date
JP2023521665A true JP2023521665A (ja) 2023-05-25
JP2023521665A5 JP2023521665A5 (https=) 2024-04-17

Family

ID=78007067

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022560235A Pending JP2023521665A (ja) 2020-04-07 2021-04-07 サケ類油組成物を使用する呼吸器処置
JP2025120711A Pending JP2025142093A (ja) 2020-04-07 2025-07-17 サケ類油組成物を使用する呼吸器処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025120711A Pending JP2025142093A (ja) 2020-04-07 2025-07-17 サケ類油組成物を使用する呼吸器処置

Country Status (10)

Country Link
US (2) US20210315941A1 (https=)
EP (1) EP4132571B1 (https=)
JP (2) JP2023521665A (https=)
KR (1) KR20230058590A (https=)
CN (1) CN115427067A (https=)
AU (1) AU2021253849A1 (https=)
BR (1) BR112022019244A2 (https=)
CA (1) CA3173877A1 (https=)
ES (1) ES3058840T3 (https=)
WO (1) WO2021207367A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102860729B1 (ko) 2024-07-02 2025-09-16 순천향대학교 산학협력단 연어 가공 부산물 가수분해물을 유효성분으로 포함하는 피부 건강 증진용 조성물
KR102804807B1 (ko) * 2024-07-31 2025-05-13 (주)아이엠엠글로벌 연어 오일 제조 방법 및 그것에 의해 제조된 연어 오일

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012087153A1 (en) * 2010-12-23 2012-06-28 Marine Bioproducts As Enrichment of marine oils with omega-3 polyunsaturated fatty acids by lipase-catalysed hydrolysis
WO2019245380A1 (en) * 2018-06-20 2019-12-26 Hofseth Biocare Asa Fish protein hydrolysate powder and a composition comprising said powder for use as a medicament

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK175501B1 (da) * 2002-12-02 2004-11-15 Green Earth Anlæg og fremgangsmåde til kontinuerlig hydrolyse af et proteinholdigt animalsk eller vegetabilsk råmateriale
KR101260533B1 (ko) * 2005-03-03 2013-05-06 가부시키가이샤 메이지 면역기능 조정제
RU2552929C1 (ru) * 2013-11-14 2015-06-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний
MY205552A (en) * 2017-05-30 2024-10-25 Deciphera Pharmaceuticals Inc Use of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl ]-3-phenylurea and analogs for the treatment of cancers associated with genetic abnormalities in platelet derived growth factor receptor alpha

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012087153A1 (en) * 2010-12-23 2012-06-28 Marine Bioproducts As Enrichment of marine oils with omega-3 polyunsaturated fatty acids by lipase-catalysed hydrolysis
WO2019245380A1 (en) * 2018-06-20 2019-12-26 Hofseth Biocare Asa Fish protein hydrolysate powder and a composition comprising said powder for use as a medicament

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ALLERGOLOGY INTERNATIONAL, vol. 64, no. 1, JPN6025001071, 2015, pages 27 - 34, ISSN: 0005505343 *
CHEST, vol. 129, no. 1, JPN6025001073, 2006, pages 39 - 49, ISSN: 0005505345 *
J OF VIROLOGY, vol. 86, no. 8, JPN6025001072, 2012, pages 4234 - 4244, ISSN: 0005505344 *

Also Published As

Publication number Publication date
JP2025142093A (ja) 2025-09-29
BR112022019244A2 (pt) 2022-11-08
KR20230058590A (ko) 2023-05-03
ES3058840T3 (en) 2026-03-13
EP4132571A1 (en) 2023-02-15
WO2021207367A1 (en) 2021-10-14
CA3173877A1 (en) 2021-10-14
AU2021253849A1 (en) 2022-09-22
EP4132571B1 (en) 2025-10-29
EP4132571A4 (en) 2024-01-17
EP4132571C0 (en) 2025-10-29
US20210315941A1 (en) 2021-10-14
US20240269196A1 (en) 2024-08-15
CN115427067A (zh) 2022-12-02

Similar Documents

Publication Publication Date Title
Liu et al. Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS
US9511107B2 (en) Phenolic compositions derived from apple skin and uses thereof
JP2025142093A (ja) サケ類油組成物を使用する呼吸器処置
WO2021143912A1 (zh) 无细胞脂肪提取液对脂肪肝及其并发症的治疗作用
WO2022089591A1 (zh) 氨基葡萄糖在制备治疗非酒精性脂肪性药物中的应用
Cvjetićanin et al. Dried leaf extract of Olea europaea ameliorates islet-directed autoimmunity in mice
Cartwright et al. The hypoxic tissue microenvironment as a driver of mucosal inflammatory resolution
Liang et al. Short-chain fatty acids: promising therapeutic targets for respiratory syncytial virus infection
US20080175888A1 (en) Combination Therapy Comprising Actinidia and Steroids and Uses Thereof
EP3955947A1 (en) Method and composition for reversing and/or inhibiting atherosclerosis
Tong et al. Peptides derived from rice α-globulin reduce atherosclerosis in apolipoprotein E-deficient mice by inhibiting TNF-α-induced vascular endothelial cells injury
CN113768956B (zh) 无细胞脂肪提取液对巨噬细胞极化调节与疾病治疗的作用
MX2007010408A (es) Composiciones que comprenden actinidia y sus metodos de uso.
JP2023521665A5 (https=)
JP2020502277A (ja) ナマコ抽出物を有効成分とするブルッフ膜機能の低下関連病気の予防および治療用組成物
HK40086292B (en) Salmonid oil compositions for use in the treatment of eosinophilic related inflammatory and respiratory conditions
HK40086292A (en) Salmonid oil compositions for use in the treatment of eosinophilic related inflammatory and respiratory conditions
KR20250127133A (ko) 면역 기능 유지 또는 개선용 조성물
TW202408482A (zh) 用於抑制免疫反應的到手香提取物
TW201720461A (zh) 預防或治療脂肪胰、改善脂肪胰引起的胰病變、糖尿病或其他相關病症之組合物及方法
JP5860803B2 (ja) 生体内の蛋白質の分解抑制剤
WO2022028375A1 (zh) 无细胞脂肪提取液对肺部疾病的治疗用途
EP4125856A1 (en) Highly purified eicosapentaenoic acid, as free fatty acid for treatment of coronaviruses and specifically novel coronavirus-19 (covid-19)
EP4523684A1 (en) Compositions comprising lipoxin-a4 and maresin-1, and uses thereof
CN101327249B (zh) 二羟基苯基乳酸在制备治疗败血症的药物中的应用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240405

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240405

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250110

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250411

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250717

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20251014